SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-018040
Filing Date
2023-05-18
Accepted
2023-05-18 08:15:33
Documents
14
Period of Report
2023-05-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 48863
2 ex99-1.htm EX-99.1 15978
3 ex99-1_001.jpg GRAPHIC 11780
  Complete submission text file 0001493152-23-018040.txt   265037

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE xtnt-20230516.xsd EX-101.SCH 3239
5 XBRL LABEL FILE xtnt-20230516_lab.xml EX-101.LAB 34916
6 XBRL PRESENTATION FILE xtnt-20230516_pre.xml EX-101.PRE 22797
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3656
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

IRS No.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34951 | Film No.: 23933760
SIC: 2836 Biological Products, (No Diagnostic Substances)